• 1. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
• 2. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 3. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 4. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 5. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazole carboxylic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazoles Pyrazole carboxylic acids and derivatives

Professional Introduction to 3-(butan-2-yl)-1H-pyrazole-5-carboxylic acid (CAS No. 949034-35-9)

3-(butan-2-yl)-1H-pyrazole-5-carboxylic acid, identified by the chemical abstracts service number CAS No. 949034-35-9, is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology due to its unique structural properties and potential biological activities. This compound belongs to the pyrazole class, which is well-documented for its diverse pharmacological effects, including anti-inflammatory, antimicrobial, and anticancer properties. The presence of a butyl substituent at the 3-position and a carboxylic acid group at the 5-position introduces specific functional characteristics that make this molecule of particular interest for further chemical modifications and biological evaluations.

The structure of 3-(butan-2-yl)-1H-pyrazole-5-carboxylic acid consists of a six-membered aromatic ring system containing two nitrogen atoms, with a butyl chain attached at the 3-position and a carboxylic acid moiety at the 5-position. This arrangement provides multiple sites for chemical derivatization, enabling the synthesis of analogues with tailored biological profiles. The pyrazole core is known to interact favorably with various biological targets, making it a versatile scaffold for drug discovery efforts.

In recent years, there has been growing interest in pyrazole derivatives as lead compounds for therapeutic intervention. Studies have demonstrated that modifications to the pyrazole ring can significantly alter its pharmacokinetic and pharmacodynamic properties. For instance, the introduction of alkyl groups at specific positions can enhance solubility and metabolic stability, while additional functional groups such as hydroxyl or amino moieties can improve binding affinity to biological receptors. The butan-2-yl substituent in 3-(butan-2-yl)-1H-pyrazole-5-carboxylic acid may contribute to increased lipophilicity, which could be advantageous for membrane permeability and oral bioavailability.

One of the most compelling aspects of this compound is its potential as a pharmaceutical intermediate. The carboxylic acid group at the 5-position allows for further functionalization via esterification, amidation, or coupling reactions, enabling the synthesis of more complex molecules. Such modifications are often employed in drug development to optimize pharmacological properties such as solubility, bioavailability, and target specificity. The flexibility offered by this scaffold makes it particularly useful for exploring novel therapeutic strategies.

Recent research has highlighted the biological significance of pyrazole derivatives, particularly in oncology and immunology. For example, certain pyrazole-based compounds have been shown to inhibit kinases involved in cancer cell proliferation or modulate immune responses in autoimmune diseases. While 3-(butan-2-yl)-1H-pyrazole-5-carboxylic acid has not yet been extensively studied in clinical trials, its structural features suggest that it may exhibit similar activities. Further investigations into its interactions with biological targets could uncover new therapeutic applications.

The synthesis of 3-(butan-2-yl)-1H-pyrazole-5-carboxylic acid typically involves multi-step organic reactions starting from readily available precursors such as butanal and hydrazine hydrate for constructing the pyrazole ring, followed by carboxylation at the 5-position. Advances in synthetic methodologies have enabled more efficient and scalable production processes, making this compound more accessible for research purposes. The ability to produce high-purity samples is crucial for accurate biological testing and characterization.

In conclusion, 3-(butan-2-yl)-1H-pyrazole-5-carboxylic acid (CAS No. 949034-35-9) represents a promising candidate for further exploration in pharmaceutical research. Its unique structural features, combined with the versatility of the pyrazole scaffold, make it an attractive molecule for developing novel therapeutics. Continued studies into its biological activity and synthetic derivatives will likely expand its utility in medicine and biotechnology.

• 92933-47-6(5-Isopropyl-1H-pyrazole-3-carboxylic acid)
• 4027-59-2(5-Ethyl-1H-pyrazole-3-carboxylic acid)
• 401629-04-7(3-Cyclopropyl-1H-pyrazole-5-carboxylic acid)
• 890624-89-2(5-Butyl-1H-pyrazole-3-carboxylic Acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)